Regulus Therapeutics Inc.
RGLS
$2.06
$0.126.19%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 218.83% | 183.64% | 153.50% | 221.88% | -39.31% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | 15.98% | 7.28% | 5.75% | 0.00% | 0.00% |
Prepaid Expenses | 125.00% | -11.48% | 156.88% | -30.31% | -27.45% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Current Assets | 192.22% | 161.35% | 142.58% | 193.52% | -36.07% |
|
|||||
Total Current Assets | 192.22% | 161.35% | 142.58% | 193.52% | -36.07% |
Net Property, Plant & Equipment | -28.64% | -21.99% | 0.85% | 0.88% | -1.44% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -24.24% | -30.56% | -30.77% | -48.28% | -46.77% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 173.76% | 148.40% | 138.55% | 208.36% | -34.18% |
|
|||||
Total Accounts Payable | 364.22% | 32.22% | 66.02% | -30.12% | 16.57% |
Total Accrued Expenses | 17.69% | 38.72% | 32.73% | 11.56% | 3.92% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -61.85% | -72.95% | -84.76% | -71.00% | -60.33% |
Total Finance Division Other Current Liabilities | -77.91% | -- | -1.82% | -6.93% | -12.50% |
Total Other Current Liabilities | -77.91% | -- | -1.82% | -6.93% | -12.50% |
Total Current Liabilities | -11.86% | -21.41% | -36.04% | -35.59% | -27.01% |
|
|||||
Total Current Liabilities | -11.86% | -21.41% | -36.04% | -35.59% | -27.01% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -74.03% | -61.61% | -52.50% | -45.68% | -40.33% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -18.72% | -26.67% | -38.47% | -37.14% | -28.77% |
|
|||||
Common Stock & APIC | 19.00% | 18.76% | 18.76% | 21.75% | 3.47% |
Retained Earnings | -9.03% | -8.24% | -7.12% | -6.40% | -6.22% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 260.70% | 207.21% | 188.82% | 304.60% | -36.36% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|||||
Total Common Equity | 260.70% | 207.21% | 188.82% | 304.60% | -36.36% |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 260.64% | 207.18% | 188.79% | 304.54% | -36.36% |
|